A pilot study examining associations between DYRK1A and α-synuclein dementias

Neurodegener Dis. 2012;10(1-4):229-31. doi: 10.1159/000334759. Epub 2012 Jan 21.

Abstract

Background: DYRK1A is a kinase targeting several proteins associated with the pathology of dementias, including α-synuclein and amyloid precursor protein. It is not clear if DYRK1A genetics are associated with neurodegenerative conditions.

Objective: To determine if DYRK1A also has a genetic association with α-synuclein dementias such as dementia with Lewy bodies and Parkinson's disease dementia.

Methods: DNA samples from prospectively followed cohorts of control and dementia individuals were genotyped for the DYRK1A rs8126696 polymorphism.

Results: The rs8126696 polymorphism altered the risk of developing an α-synuclein-associated dementia.

Conclusion: DYRK1A could prove to be an important therapeutic target as it interacts with several proteins associated with the development of pathology in dementia.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism
  • Analysis of Variance
  • Cohort Studies
  • DNA Mutational Analysis
  • Dyrk Kinases
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Intermediate Filament Proteins / metabolism*
  • Lewy Body Disease / genetics*
  • Lewy Body Disease / metabolism*
  • Male
  • Pilot Projects
  • Polymorphism, Genetic / genetics*
  • Protein Serine-Threonine Kinases / genetics*
  • Protein-Tyrosine Kinases / genetics*
  • Psychiatric Status Rating Scales

Substances

  • Intermediate Filament Proteins
  • desmuslin
  • Protein-Tyrosine Kinases
  • Protein Serine-Threonine Kinases